FDCTech Inc (FDCT): On December 31, 2022, and 2021, we had a...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

FDCTech Inc (FDCT)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	45
Posts	2597
Boards Moderated	8
Alias Born	01/28/2001

Re: None

Thursday, 05/04/2023 11:50:06 AM

Thursday, May 04, 2023 11:50:06 AM

On December 31, 2022, and 2021, we had a cash balance of $264,829 and $93,546, respectively. At December 31, 2022, and 2021, the working capital surplus and deficit were $541,359 and $199,132, respectively. The increase in the working capital surplus was mainly due to the acquisition of NSFX, resulting in the increase of current assets over current liabilities as of December 31, 2022.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent FDCT News

Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/26/2024 10:12:50 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/03/2024 10:17:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 05:27:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:35:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 02:30:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:58:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:11 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 05:32:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 07:00:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:45:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 07:00:46 PM

More FDCT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow